COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors
Fernando Alarid Escudero, Profesor Investigador Titular de la División de Administración Pública del CIDE, junto con Elizabeth T. Chin, Theresa Ryckman, Lea Prince, David Leidner, Jason R. Andrews, Joshua A. Salomon, David M. Studdert y Jeremy D. Goldhaber-Fiebert escribieron el artículo COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors en el Journal of General Internal Medicine.
Over 380,000 incarcerated people in the USA were diagnosed with severe acute respiratory syndrome coronavirus 2 through February 2021, and approximately 2,300 died. Prisons are vulnerable to rapid viral spread, given their population density and the infeasibility of standard distancing measures. COVID-19-related health outcomes appear worse among incarcerated people than in the general population.
Correctional systems face difficult trade-offs in their attempts to control COVID-19 transmission. Early releases reduce crowding but may cause public unrest. Curtailing in-prison activities (e.g., work or group therapy) limits mixing but is disruptive and may have adverse health effects. The federal government has issued guidance on measures to reduce COVID-19 transmission in correctional settings, but the recommendations lack specificity and evidence of efficacy. The evidence base in this area remains extremely limited.